Evidence map›Paper›PMID 34795434›Full record

ArticleNature chemistry2022

A versatile approach for the synthesis of degradable polymers via controlled ring-opening metathesis copolymerization.

John D Feist, Daniel C Lee, Yan Xia

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Ring-Opening Metathesis Polymerization of 1,2-Dihydroazete Derivatives.Angewandte Chemie (International ed. in English) · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

John D FeistDepartment of Chemistry, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4032-1418
Daniel C LeeDepartment of Chemistry, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4986-6027
Yan XiaDepartment of Chemistry, Stanford University, Stanford, CA, USA. yanx@stanford.edu.ORCID http://orcid.org/0000-0002-5298-748X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Norbornene derivatives (NBEs) are common monomers for living ring-opening metathesis polymerization and yield polymers with low dispersities and diverse functionalities. However, the all-carbon backbone of poly-NBEs is non-degradable. Here we report a method to synthesize degradable polymers by copolymerizing 2,3-dihydrofuran with NBEs. 2,3-Dihydrofuran rapidly reacts with Grubbs catalyst to form a thermodynamically stable Ru Fischer carbene-the only detectable active Ru species during copolymerization-and the addition of NBEs becomes rate determining. This reactivity attenuates the NBE homoaddition and allows uniform incorporation of acid-degradable enol ether linkages throughout the copolymers, which enables complete polymer degradation while maintaining the favourable characteristics of living ring-opening metathesis polymerization. Copolymerization of 2,3-dihydrofuran with NBEs gives low dispersity polymers with tunable solubility, glass transition temperature and mechanical properties. These polymers can be fully degraded into small molecule or oligomeric species under mildly acidic conditions. This method can be readily adapted to traditional ring-opening metathesis polymerization of widely used NBEs to synthesize easily degradable polymers with tunable properties for various applications and for environmental sustainability.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.